Due to the small number of publications available on this topic, it seems extremely important to summarize and determine the current state of knowledge on the utility of APRIL in cancer initiation and its usefulness in the detection and therapy of CRC, which was the main aim of our work. The gene discussed is TNFSF13; the disease is cancer.